Target Audience

This activity is specifically designed for:

  • Regulators

  • Policy makers

Learning Objectives

At the end of the course, learners should be able to:

  • Explain trade-offs between accuracy, accessibility, affordability and time-to-result

  • Detail key considerations in balancing risks and benefits using COVID-19 tests as examples


With countries committed to universal access to health care and leaving no one behind and the need for widespread testing for the COVID-19 pandemic, we will examine how trade-offs need to be made between test accuracy, accessibility affordability and time to result using case studies. Addressing these issues, the agenda is as follows:

  • Accuracy vs. Access (HIV Rapid Tests)

  • Accuracy vs Accessibility and Time-to-Result (Early Infant Diagnosis of HIV)

  • Test Sensitivity vs Testing Frequency and Time-to-Result (COVID-19)

  • Trade-offs Between Accuracy, Accessibility, Affordability and Time-to-Result of in-vitro Diagnostics

Course Directors

Professor Rosanna Peeling, London School of Hygiene & Tropical Medicine, UK

Professor David Heymann, London School of Hygiene & Tropical Medicine, UK


  • Dr. Noah Fongwen, London School of Hygiene and Tropical Medicine & Africa CDC, UK

  • Scott Chiossi, Chatham House, UK

  • Carlos Gouvea, Latin American Alliance for In Vitro Diagnostic Development (ALADDiV), Brazil

  • Dr. Sidney Yee, DxD Hub, Association of Southeast Asian Nations (ASEAN), Singapore

  • Dr. Jaime Montoya, Council for Health Research and Development, Association of Southeast Asian Nations (ASEAN), Philippines

Learn more!

Add your email to the mailing list to get the latest updates.